News

As the population of survivors of cancer 65 and older will likely double in size during the next two decades, the review reveals an urgent need for research to address biases impacting cancer outcomes in older people.

A novel urine-based test that measures 18 markers can accurately detect high-grade prostate cancer, potentially reducing the need for invasive biopsies.

Blocking oxygen-sensing enzymes in cancer cells can significantly halt acute myeloid leukemia in patient samples without affecting the production of normal blood cells.

Researchers, using an experiment that elucidated the function of tens of thousands of noncoding variants, discovered a link between functional mutations and genes linked to cancer pathways, as well as indicators to predict cancer patient survival.

Using a novel imaging technique to view cells in 3D, researchers have been able to identify two genes that control how melanoma skin cancer cells change shape – offering potential drug targets to prevent the cancer from spreading.

New research explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy can successfully treat this rare and aggressive cancer.

Women with triple-negative breast cancer and high levels of immune cells in the tumor have a lower risk of relapse after surgery, even without chemotherapy.

For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.

Researchers have discovered that tetracycline antibiotics help the immune system to find cancer cells in a way that is different from current immunotherapies.

Researchers have developed a urine-based test that can detect DNA fragments released by head and neck cancers, potentially facilitating early diagnosis.